Skip to content

Sunday, February 22, 2026

Latest:

Access to life saving medications matters – that includes obesity
FROM THE LABS: Tracing a path from genetic changes to Parkinson’s disease opens possibilities for early diagnosis
Healthy Habits: Dr. Thanila De Araujo Macedo enjoys biking
Weighted Blankets – the best weight on your shoulders?
FROM THE LABS: A ‘sticky situation’ boosts triple negative breast cancer’s ability to metastasize

Home
Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
Policywise
- About PolicyWise
- Follow @BCMEthics on Twitter
The Stitch
- About The Stitch
Progress Notes
bcm.edu

ACTL6A

A new mechanism of cisplatin resistance in cancer, and how to reverse it

April 22, 2021 ACTL6A, cancer resistance to therapy, cisplatin, DNA repair, epigenetic chromatin remodeling, panobinostat, Research

ACLT6A overexpression confers cancer cells resistance to cisplatin, and researchers found a way to reverse it.

From the Labs: Image of the Month

From the Labs: Human intestinal organoid

Healthy Habits: A DOC-umentary Series

Archives

Archives

Search

©1998 - 2023 Baylor College of Medicine®
One Baylor Plaza, Houston, Texas 77030
(713) 798-4951